ADIM
TROW icon

Alpha DNA Investment Management’s T. Rowe Price TROW Stock Holding History

Alpha DNA Investment Management’s Portfolio TROW Stock Details TROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-348
Closed -$59K – 606
2021
Q1 		$59K Sell
348
-20
-5% -$3.28K 0.07% 151
2020
Q4 		$55K Buy
+368
New +$52.6K 0.06% 169

Other funds holding TROW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha DNA Investment Management's TROW Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of T. Rowe Price (TROW) in Q2 2021, closing a stake of 348 shares — an estimated $59K sold.

Alpha DNA Investment Management first reported a position in TROW in Q4 2020 and held it in 2 quarters. The position peaked at $59K in Q1 2021. 1,075 funds tracked by Wall St. Rank hold TROW as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining T. Rowe Price position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 348 T. Rowe Price shares in Q2 2021, an estimated $59K.
  • Alpha DNA Investment Management first reported a position in T. Rowe Price in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's T. Rowe Price position peaked at $59K in Q1 2021.
  • 1,075 funds tracked by Wall St. Rank held T. Rowe Price as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.